Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

NCT00591123 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Adenocarcinoma of the Esophagus
Metastatic Adenocarcinoma of the Esophagus
Unresectable Adenocarcinoma of Gastric Cardia
Metastatic Adenocarcinoma of Gastric Cardia

Interventions

DRUG: FOLFOX
DRUG: 5-FU
DRUG: Erlotinib

Sponsor

Translational Oncology Research International

Collaborators

[object Object]
[object Object]
[object Object]